(function(){var loadHandler=window['sl_{72C0429F-FC8A-44E7-B152-D6826999A52C}'];loadHandler&&loadHandler(132, '<div id="spr0_42c1c2f1"><div id="spr1_42c1c2f1" class="kern slide"><img id="img0_42c1c2f1" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_42c1c2f1" class="kern slide"><div id="spr3_42c1c2f1" style="left:169.238px;top:158.347px;"><div style="width:0px;"><span id="txt0_42c1c2f1" data-width="140.132813" style="left:128.53px;top:0.564px;">~20% Early BC</span></div><div style="width:0px;"><span id="txt1_42c1c2f1" data-width="360.263672" style="left:21.715px;top:30.123px;">Progression in neo-adjuvant setting (pre-surgical)</span></div><div style="width:0px;"><span id="txt2_42c1c2f1" data-width="313.022461" style="left:45.27px;top:51.723px;">Relapses in adjuvant setting (after surgery)</span></div><div style="width:0px;"><span id="txt3_42c1c2f1" data-width="235.171875" style="left:83.915px;top:94.164px;">up to 90% Advanced BC</span></div><div style="width:0px;"><span id="txt4_42c1c2f1" data-width="384.820313" style="left:9.145px;top:123.723px;">progression within 3-5 years in disseminated disease</span></div><div style="width:0px;"><span id="txt5_42c1c2f1" data-width="178.757813" style="left:111.87px;top:166.164px;">Primary (intrinsic)</span></div><div style="width:0px;"><span id="txt6_42c1c2f1" data-width="313.936523" style="left:44.61px;top:195.723px;">No response to neo-adjuvant (pre-surgical)</span></div><div style="width:0px;"><span id="txt7_42c1c2f1" data-width="276.152344" style="left:63.645px;top:217.323px;">Relapse within 1-2 years after surgery</span></div><div style="width:0px;"><span id="txt8_42c1c2f1" data-width="370.045898" style="left:16.465px;top:238.923px;">Progression within 2-6 months in advanced setting</span></div><div style="width:0px;"><span id="txt9_42c1c2f1" data-width="211.289063" style="left:95.64px;top:281.364px;">Secondary (acquired)</span></div><div style="width:0px;"><span id="txt10_42c1c2f1" data-width="263.540039" style="left:69.32px;top:310.923px;">After an evidence of initial response</span></div></div><div id="spr4_42c1c2f1" style="top:95.683px;"><div style="width:0px;"><span id="txt11_42c1c2f1" data-width="573.630859" style="left:74.355px;top:0.058px;">Relapse or progression on an endocrine treatment</span></div></div><div id="spr5_42c1c2f1" style="top:3.284px;"><div style="width:0px;"><span id="txt12_42c1c2f1" data-width="303.626953" style="left:104.791px;top:-0.954px;">Endocrine resistance</span></div></div></div></div>');})();